These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31564516)

  • 1. The impact of intensified clinical care on glycaemic control in patients with type 2 diabetes at Khayelitsha Community Health Centre, South Africa: Quasi-experimental study.
    Allerton J; Mash R
    Prim Care Diabetes; 2020 Apr; 14(2):97-103. PubMed ID: 31564516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus.
    Güner TA; Coşansu G
    Prim Care Diabetes; 2020 Oct; 14(5):482-487. PubMed ID: 32471770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    van den Burg EL; Schoonakker MP; van Peet PG; van den Akker-van Marle EM; Lamb HJ; Longo VD; Numans ME; Pijl H
    Diabetologia; 2024 Jul; 67(7):1245-1259. PubMed ID: 38546821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy.
    Ribeiro RT; Andrade R; Nascimento do Ó D; Lopes AF; Raposo JF
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1267-1275. PubMed ID: 33612381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control.
    Trivedi H; Gray LJ; Seidu S; Davies MJ; Charpentier G; Lindblad U; Kellner C; Nolan J; Pazderska A; Rutten G; Trento M; Khunti K
    Prim Care Diabetes; 2017 Oct; 11(5):414-420. PubMed ID: 28684227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care testing improves diabetes management in a primary care clinic in South Africa.
    Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P
    Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in Tshwane primary health care clinics, South Africa.
    Webb EM; Rheeder P
    Prim Care Diabetes; 2017 Dec; 11(6):546-554. PubMed ID: 28690088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.
    Elliott T; Beca S; Beharry R; Tsoukas MA; Zarruk A; Abitbol A
    Diab Vasc Dis Res; 2021; 18(4):14791641211021374. PubMed ID: 34275385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.
    Chepulis L; Morison B; Cassim S; Norman K; Keenan R; Paul R; Lawrenson R
    J Diabetes Res; 2021; 2021():5531146. PubMed ID: 34136579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring reasons for very poor glycaemic control in patients with Type 2 diabetes.
    Khan H; Lasker SS; Chowdhury TA
    Prim Care Diabetes; 2011 Dec; 5(4):251-5. PubMed ID: 21782539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
    Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
    Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes.
    Berra CC; Resi V; Mirani M; Folini L; Rossi A; Solerte SB; Fiorina P
    Pharmacol Res; 2020 Sep; 159():104996. PubMed ID: 32574827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control among patients with type 2 diabetes followed in a rural African primary care setting - A reality check in the Democratic Republic of Congo.
    Blum J; Chaney M; Mudji J; Mfungwa JK; Rice T; Labhardt ND
    Prim Care Diabetes; 2020 Apr; 14(2):139-146. PubMed ID: 31455548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study.
    Abitbol A; Jain AB; Tsoukas MA; Sigalas J; Galm BP; Lee J; Qureshy KS; Collins C; Woo VC
    Diab Vasc Dis Res; 2024; 21(3):14791641241253967. PubMed ID: 38733368
    [No Abstract]   [Full Text] [Related]  

  • 17. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
    Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
    Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.